Pheochromocytoma of the pancreas: A report of three cases and a literature review

  • Authors:
    • Min Yang
    • Hui Ding
    • Min Cai
    • Yan‑An He
    • Yu Cai
    • Yong Zeng
    • Bo‑Le Tian
  • View Affiliations

  • Published online on: June 15, 2016     https://doi.org/10.3892/ol.2016.4721
  • Pages: 959-962
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Pheochromocytoma is primarily derived from the adrenal medulla. The majority of extra-adrenal pheochromocytoma cases occur in the superior para‑aortic region and para‑adrenal area. However, pheochromocytoma originating from the pancreas is rare. The present study reports the cases of three patients who had no history of hypertension but were post‑operatively diagnosed with pheochromocytoma located in the pancreas. Of the three patients, two were admitted to hospital due to abdominal pain, and imaging examinations revealed a soft‑tissue lesion in the head of pancreas. Local resection of the pancreatic tumor was successfully performed and a diagnosis of pheochromocytoma derived from the pancreas was subsequently made by pathologists. The third patient was admitted to hospital for surgical treatment due to the identification of a continuously growing lesion in the tail of pancreas during physical examinations. Distal resection of the pancreas was stopped during surgery when the patient's blood pressure and heart rate suddenly increased to 180/110 mmHg and 140 beats/min, respectively. Due to a marked rise in noradrenaline and adrenaline levels in the blood subsequent to surgery, the patient was diagnosed with pancreatic pheochromocytoma. The present study additionally reviewed the associated literature concerning pheochromocytoma in order to improve the understanding of this rare clinical phenomenon. The aim of the present study is to highlight to surgeons that although patients may not present with typical clinical manifestations due to the non‑functional status of the tumor, undiagnosed pheochromocytoma of the pancreas should be considered when surgeons observe an unexpected hypertensive crisis during pancreatic tumor surgery.

Introduction

Pheochromocytoma is a catecholamine-secreting tumor that originates from chromaffin cells. The majority of these tumors arise in the adrenal medulla (1), and when they occur outside the adrenal gland they are known as an extra-adrenal pheochromocytoma or a paraganglioma (2). Pheochromocytoma is primarily sporadic, but may additionally be associated with multiple endocrine neoplasia syndrome (3) and mutations of mitochondrial complex 2 succinate dehydrogenase enzymes (4).

Extra-adrenal pheochromocytoma has been previously reported to account for ~10% of all pheochromocytoma cases during adulthood and for 30–40% of cases in children (5). These tumors may occur in the superior para-aortic region, the para-adrenal area and the inferior para-aortic region, as well as the organ of Zuckerkandl and the urinary bladder (68). Pancreatic localization of extra-adrenal pheochromocytoma is rare, and to the best of our knowledge, only one case has been previously reported in the Chinese literature (9). In the present study, the cases of three patients (Table I) with pheochromocytoma involving the pancreas are presented. To the best of our knowledge, the present report is the first to present three definite and comprehensive cases of this rare clinical phenomenon. In addition, the relevant literature is reviewed, with the aim of improving the understanding of pheochromocytoma, with an emphasis on sharing patient experiences of diagnosis and surgical treatment.

Table I.

Clinical features of three patients with pancreatic pheochromocytoma.

Table I.

Clinical features of three patients with pancreatic pheochromocytoma.

VariableCase 1Case 2Case 3
GenderFemaleMaleFemale
Age, years554430
HypertensionNoNoNo
Family historyNoNoNo
Chief complaintAbdominal painAbdominal painNeoplasm detected on routine physical examination
Tumor locationUncinate processUncinate processPancreatic tail
Tumor size, cm2.53.26
SurgeryLocal resectionLocal resectionLaparotomy
ComplicationsNoPancreatic fistulaMortality
Patient outcomeAliveAliveSuccumbed

Case report

Case 1

A 55-year-old female was admitted to the People's Hospital of Jiangyou (Mianyang, China) in February 2013 with the symptom of recurrent abdominal pain over a period of >3 years. On admittance, the patient did not exhibit any weight loss, changes in appetite or bowel habits, jaundice or non-specific symptoms associated with hypertension, including palpitations, sweating, headache, dizziness or fainting. The patient's physical examination and pre-operative routine examinations did not identify any significant abnormalities. Serum tumor markers for cancer antigen 19-9, cancer antigen 125 and carcinoembryonic antigen (CEA) were additionally observed to be within the normal ranges. The patient underwent ultrasound (US) and computed tomography (CT; LightSpeed VCT CT system; GE Healthcare Life Sciences, Chalfont, UK), which revealed a mass in the uncinate process of the pancreas, with a diameter of ~2.5 cm. Due to suspicions of a pancreatic malignant tumor, an exploratory laparotomy was performed, which confirmed the location of the mass in the uncinate process of the pancreas, with a relatively clear association with the surrounding tissues. A local resection of the pancreatic tumor was subsequently successfully performed. Resected tissue was formalin (Beijing Noble Ryder Technology Co., Ltd., Beijing, China)-fixed, paraffin (Beijing Noble Ryder Technology Co., Ltd.)-embedded and cut into 4-µm sections. For histological examination, the tissue sections were stained with hematoxylin and eosin (Haibiao Technology, Co., Ltd., Xiamen, China) and observed under a microscope (CX31; Olympus Coropration, Tokyo, Japan). Pathologists were able to histologically diagnose the tumor as pancreatic paraganglioma (extra-adrenal pheochromocytoma originating from the pancreas). The tumor cells were polygonal, had abundant cytoplasm and contained basophilic or amphotropic particles The nuclei were round or irregular, and the tumor cells were arranged in cords or nests. According to the introperative and histological findings, the tumor was 2.5 and 3 cm in diameter, respectively. There was no evidence of distant metastasis, and no direct tissue or arterial or venous invasion. For immunohistochemical analysis, tissue sections were incubated with monoclonal mouse anti-human chromogranin A (CgA; cat. no. ZA0507; 1:50; Beijing Zhongshan Golden Bridge Biotechnology Co., Ltd., Beijing, China), monoclonal mouse anti-human synaptophysin (Syn; cat. no. M077629; 1:100; Dako, Glostrup, Denmark), S-100 (cat. no. ZA0507; 1:100; Beijing Zhongshan Golden Bridge Biotechnology Co., Ltd.), monoclonal rabbit anti-human vimentin (cat. no. M072529; 1:50; Dako) and monoclonal mouse anti-human CEA (cat. no. ZA0507; 1:100; Beijing Zhongshan Golden Bridge Biotechnology Co., Ltd.) antibodies at 4°C for 12 h and visualized under a microscope (CX31; Olympus Corporation). Immunohistochemical examination (Fig. 1A and B) revealed that the tumor was positive for S-100, CgA, Syn, vimentin and CEA expression. The patient recovered well following the procedure and was discharged 11 days post-surgery.

Case 2

A 44-year-old man, who had experienced continuous upper abdominal pain for 6 months was admitted to the People's Hospital of Jiangyou in March 2012. The patient demonstrated no notable abnormalities on physical examination and serum biochemical tests. In addition, the patient did not have a history of hypertension or a remarkable family history. CT scanning revealed a soft-tissue lesion located in the pancreatic uncinate process, measuring 3.2×3 cm, together with a normal pancreatic duct and common bile duct. The presence of the lesion was confirmed by magnetic resonance imaging (MRI; GE 1.5T Signa HDe; GE Healthcare Life Sciences). Due to concerns over the presence of an undetected malignancy, a diagnostic laparotomy was performed, which confirmed that the mass was located in the uncinate process of the pancreas without distorting the surrounding tissues. During surgery, fast-frozen pathological testing of the resected mass indicated a tumor-like lesion, which was suspected to be a high-grade pancreatic neuroendocrine tumor or cystic adenoma. A histological diagnosis of pancreatic pheochromocytoma was confirmed by pathologists following successful local resection of the pancreatic tumor. The tumor cells of the resected tissue were positive for S-100, Syn, CgA and inhibin expression (Fig. 1C). The patient experienced the post-operative complication of a pancreatic fistula, which was treated with drug therapy (0.1 mg sandostatin subcutaneously injected 3 times/day for 7 days) and percutaneous drainage, which prolonged the duration of the patient's hospital stay. The patient was subsequently discharged almost 2 months after surgery.

Case 3

A 30-year-old woman was admitted the West China Hospital of Sichuan University (Chengdu, China) in August 2011 due to the positive identification of a neoplasm in the pancreatic tail during routine abdominal US. The patient did not exhibit any typical symptoms associated with this disease, and had no history of hypertension. A physical examination and tumor-associated marker evaluation revealed no abnormalities. Following admission to hospital, abdominal enhanced CT detected a mass, ~6 cm in size, situated in the tail of the pancreas (Fig. 1D). Considering the rapid growth of the tumor and its potential malignancy, a laparotomy was suggested and subsequently performed. However, during surgery, the patient's heart rate and blood pressure suddenly increased to 140 beats/min and 180/110 mmHg, respectively, as surgeons attempted to dissect the neoplasm. The patient's vital signs were unstable and uncontrollable, which led the surgeons to hypothesize that the tumor may be a pheochromocytoma of the pancreas. Following an emergency consultation, the planned surgery was halted and the patient was transferred immediately to the intensive care unit. The patient's post-surgical blood plasma test revealed noradrenaline and adrenaline levels of 318,306 and 346,940 ng/l, respectively (normal range, <174,357 and <60,104 ng/l, respectively), which confirmed the diagnosis of a pheochromocytoma of the pancreas. Due to an unstable post-operative heart rate and blood pressure, the patient succumbed to heart failure.

Discussion

Owing to excessive secretion of catecholamines, pheochromocytoma may cause life-threatening symptoms, including hypertension, cardiac arrhythmias, headaches and palpitations (1). However, clinical manifestations of this tumor are variable and non-specific, and in certain cases, the clinical symptoms are not clear. It has been reported that ~70% of extra-adrenal pheochromocytoma cases are non-functional and only ~30% of patients may manifest with different presentations; however, the number of patients who do not present with typical symptoms is increasing (10,11).

Due to variable and non-specific manifestations, a diagnosis of extra-adrenal pheochromocytoma is difficult and dependent on clinician experience (1,2,5). In general, a pre-operative diagnosis of extra-adrenal pheochromocytoma is established by taking into account the presence of clinical signs, the determination of catecholamines and their metabolites in blood or urine, and the presence of a mass in the extra-adrenal region. Imaging examinations (US, CT and MRI) are primarily used for locating the lesion, and additionally provide reference values for final histological diagnosis. As previously mentioned, pheochromocytoma derived from the pancreas is seldom observed. Guo et al (9) reported the first pancreatic pheochromocytoma in the Chinese literature: The patient was 40-year-old women that had a mass on the left-upper side of the abdomen for >1 month. The patient did not have abdominal pain, distension or discomfort, or a history of trauma, fever, headache, dizziness or high blood pressure. A gigantic pheochromocytoma was identified in the tail of pancreas, and the patient underwent surgery, from which the patient recovered well. The three patients in the present study did not have a history of hypertension nor the typical symptoms associated with this disease. The tumors of the first two patients were located in the uncinate process of the pancreas and were successfully resected. No significant changes in blood pressure or heart rate were detected during surgery, and the diagnosis of a pancreatic pheochromocytoma was primarily based on the pathological and immunohistochemical examination of the resected tissues following surgery. The third patient did not experience any discomfort, but presented with a positive indication of a neoplasm situated in the tail of the pancreas, for which a distal resection was planned as a treatment strategy. However, the surgery was halted intraoperatively due to a sudden increase in the patient's blood pressure and heart rate. Due to a marked post-operative increase in noradrenaline and adrenaline levels in the patient's blood plasma, a diagnosis of pheochromocytoma located in the pancreas was established.

Pheochromocytoma originates in chromaffin cells derived from primitive neural crest cells, which may react and stain with chromic salts (8). Furthermore, pheochromocytoma or paraganglioma in the pancreas, to a certain extent, is a type of pancreatic neuroendocrine tumor (pNET), which means that the tumor cells of resected tumors may demonstrate positive reactions for CgA and Syn following immunohistochemical staining (12). With regard to the first two cases presented here, this pathological feature is of significant value for histological diagnosis of pancreatic pheochromocytoma.

Surgery is the only curative treatment for pNET and pancreatic pheochromocytoma (13). If pheochromocytoma of the pancreas is suspected, surgery should be suggested. Prior to this, pre-operative assessments should be managed for a certain period of time in case of sudden large increases in blood pressure and heart rate. Exploratory laparotomy is a method of diagnosis, but if there are not enough pre-operative preparations, surgery may lead to sudden hypertension resulting in patient mortality, as occurred in the third case reported in the present study. For surgeons who encounter an unexpected hypertensive crisis during pancreatic tumor surgery, an undiagnosed pheochromocytoma of the pancreas should be immediately considered. The surgery should be halted, and appropriate preparations should then be made for a safer second attempt at the surgery.

References

1 

Werbel SS and Ober KP: Pheochromocytoma. Update on diagnosis, localization, and management. Med Clin North Am. 79:131–153. 1995. View Article : Google Scholar : PubMed/NCBI

2 

Sandur S, Dasgupta A, Shapiro JL, Arroliga AC and Mehta AC: Thoracic involvement with pheochromocytoma: A review. Chest. 115:511–521. 1999. View Article : Google Scholar : PubMed/NCBI

3 

Neumann HP, Berger DP, Sigmund G, Blum U, Schmidt D, Parmer RJ, Volk B and Kirste G: Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hipple-Lindau disease. N Engl J Med. 329:1531–1538. 1993. View Article : Google Scholar : PubMed/NCBI

4 

Gimm O, Armanios M, Dziema H, Neumann HP and Eng C: Somatic and occult germ-line mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma. Cancer Res. 60:6822–6825. 2000.PubMed/NCBI

5 

Atiyeh BA, Barakat AJ and Abumrad NN: Extra-adrenal pheochromocytoma. J Nephrol. 10:25–29. 1997.PubMed/NCBI

6 

Schwartz EL, Mao P, Hernried O, Born EE and Waldmann EB: Catecholamine-secreting paraganglioma. The problem of classification. Arch Intern Med. 135:978–985. 1975. View Article : Google Scholar : PubMed/NCBI

7 

Stackpole RH, Melicow MM and Uson AC: Pheochromocytoma in children. Report of 9 cases and review of the first 100 published cases with follow-up studies. J Pediatr. 63:314–330. 1963.PubMed/NCBI

8 

Madani R, Al-Hashmi M, Bliss R and Lennard TW: Ectopic pheochromocytoma: Does the rule of tens apply? World J Surg. 31:849–854. 2007. View Article : Google Scholar : PubMed/NCBI

9 

Guo XY, Wang XJ and Yang JY: A gigantic pheochromocytoma in the tail of the pancreas. He Bei Yi Yao. 13:16282009.(In Chinese).

10 

Birrenbach T, Stanga Z, Cottagnoud P and Stucki A: Unexpected metastatic pheochromocytoma - an unusual presentation. Eur J Intern Med. 19:60–62. 2008. View Article : Google Scholar : PubMed/NCBI

11 

Parmer RJ and Zinder O: Catecholaminergic pathways, chromaffin cells, and human disease. Ann NY Acad Sci. 971:497–505. 2002. View Article : Google Scholar : PubMed/NCBI

12 

Panzuto F, Severi C, Cannizzaro R, Falconi M, Angeletti S, Pasquali A, Corleto VD, Annibale B, Buonadonna A, Pederzoli P and Delle Fave G: Utility of combined use of plasma levels of chromogranin A and pancreatic polypeptide in the diagnosis of gastrointestinal and pancreatic endocrine tumors. J Endocrinol Invest. 27:6–11. 2004. View Article : Google Scholar : PubMed/NCBI

13 

Halfdanarson TR, Rabe KG, Rubin J and Petersen GM: Pancreatic neuroendocrine tumors (PNETs): Incidence, prognosis and recent trend toward improved survival. Ann Oncol. 19:1727–1733. 2008. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

August-2016
Volume 12 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yang M, Ding H, Cai M, He YA, Cai Y, Zeng Y and Tian BL: Pheochromocytoma of the pancreas: A report of three cases and a literature review. Oncol Lett 12: 959-962, 2016.
APA
Yang, M., Ding, H., Cai, M., He, Y., Cai, Y., Zeng, Y., & Tian, B. (2016). Pheochromocytoma of the pancreas: A report of three cases and a literature review. Oncology Letters, 12, 959-962. https://doi.org/10.3892/ol.2016.4721
MLA
Yang, M., Ding, H., Cai, M., He, Y., Cai, Y., Zeng, Y., Tian, B."Pheochromocytoma of the pancreas: A report of three cases and a literature review". Oncology Letters 12.2 (2016): 959-962.
Chicago
Yang, M., Ding, H., Cai, M., He, Y., Cai, Y., Zeng, Y., Tian, B."Pheochromocytoma of the pancreas: A report of three cases and a literature review". Oncology Letters 12, no. 2 (2016): 959-962. https://doi.org/10.3892/ol.2016.4721